HIV-1 pretreatment and acquired antiretroviral drug resistance before tenofovir/ /lamivudine /dolutegravir (TLD) roll-out in Mozambique.
Saved in:
| Title: | HIV-1 pretreatment and acquired antiretroviral drug resistance before tenofovir/ /lamivudine /dolutegravir (TLD) roll-out in Mozambique. |
|---|---|
| Authors: | Ismael N; Instituto Nacional de Saúde, EN1, Bairro da Vila - Parcela N˚3943, Marracuene Sede, Marracuene, Maputo Province, Mozambique. nalia.ismael@ins.gov.mz.; Division of Medical Virology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. nalia.ismael@ins.gov.mz., Gemusse H; Instituto Nacional de Saúde, EN1, Bairro da Vila - Parcela N˚3943, Marracuene Sede, Marracuene, Maputo Province, Mozambique., Mahumane I; Instituto Nacional de Saúde, EN1, Bairro da Vila - Parcela N˚3943, Marracuene Sede, Marracuene, Maputo Province, Mozambique., Laurindo O; Instituto Nacional de Saúde, EN1, Bairro da Vila - Parcela N˚3943, Marracuene Sede, Marracuene, Maputo Province, Mozambique., Magul C; Instituto Nacional de Saúde, EN1, Bairro da Vila - Parcela N˚3943, Marracuene Sede, Marracuene, Maputo Province, Mozambique., Baxter C; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Cape Town, South Africa., Wilkinson E; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Cape Town, South Africa., Hofstra LM; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Cape Town, South Africa., Wagar N; Division of Global HIV & TB, U.S. Centers for Diseases Control and Prevention, Atlanta, USA., Bila D; Fundação Ariel Glaser Contra o SIDA Pediátrico, Maputo City, Mozambique., Mabunda N; Instituto Nacional de Saúde, EN1, Bairro da Vila - Parcela N˚3943, Marracuene Sede, Marracuene, Maputo Province, Mozambique., da Silva J; Division of Global HIV & TB, U.S. Centers for Diseases Control and Prevention, Atlanta, USA., Oliveira T; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Cape Town, South Africa., Raizes E; Division of Global HIV & TB, U.S. Centers for Diseases Control and Prevention, Atlanta, USA., Preiser W; Division of Medical Virology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Manuel P; Division of Global HIV & TB, U.S. Centers for Diseases Control and Prevention, Maputo City, Mozambique., Ramos A; Division of Global HIV & TB, U.S. Centers for Diseases Control and Prevention, Maputo City, Mozambique., Vúbil A; Instituto Nacional de Saúde, EN1, Bairro da Vila - Parcela N˚3943, Marracuene Sede, Marracuene, Maputo Province, Mozambique. |
| Source: | BMC infectious diseases [BMC Infect Dis] 2024 Jul 29; Vol. 24 (1), pp. 748. Date of Electronic Publication: 2024 Jul 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1471-2334 |
|---|---|
| DOI: | 10.1186/s12879-024-09579-4 |
